Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Postdoctoral position - Tumor Microenvironment and Metastasis - Labelle Lab Postdoctoral position - Tumor Microenvironment and Metastasis - Labelle Lab A postdoctoral position is available in
-
for extension - employee level. Salary: € 40K The position is based in Milan (IT) “The Foundation reserves the right, at its sole discretion, to extend, suspend, modify, revoke, or cancel this job posting
-
for extension - employee level. Salary: € 40K The position is based in Milan (IT) “The Foundation reserves the right, at its sole discretion, to extend, suspend, modify, revoke, or cancel this job posting
-
. The working environment is very collaborative and PhD students and postdocs are encouraged to develop they own independent projects Place of work and area of employment The place of work is Bioinformatics
-
shuttle bus Start date: As soon as possible Fixed-term: 2 years Salary: The position is classed as salary group 13 according to “TVöD Bund (Tarifgebiet Ost)”. The salary group is determined on the basis
-
thereafter. The position is a fixed-term full-time position for 27 months. The Department of Biomedicine prioritises diversity and a good work environment, as this is a prerequisite for groundbreaking research
-
, and positioning for subsequent fundraising and go-to-market activities Actively contribute to securing follow-up funding together with the fundraising team Your profile University degree (MSc or PhD) in
-
A post-doctoral position in human population genomics is opening in our lab to work on the POPGEN project. The POPGEN project is a pilot research project developed in the framework of the French
-
allowances, flexible working, pension scheme and relocation package (if applicable). Job category/type: Research Job reference: Q07290 Faculty of Health and Life Sciences This new full-time post is immediately
-
. The postdoctoral position is part of the Carl Zeiss Foundation-funded “ImmuneMPS” consortium, which aims to develop microphysiological systems to advance understanding of cancer–immune interactions. The consortium